Fondazione Italiana Sclerosi Multipla   Report issue

Foundation Phase 1
Founded: Rome Italy (1968)

Organization Overview

First Clinical Trial
2017
NCT03269071
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Fondazione Italiana Sclerosi Multipla

Active Ingredients

Drugs in Phase 1 Trials (1)

fetal-derived neural stem cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Multiple Sclerosis (Phase 1)

Sclerosis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1